InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+13.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Farkas Charles, Director. Insider active across 1 company, notably CONMED Corp. Aggregated, 10 reports have been published. Breakdown: 1 buy · 1 sell. Total volume traded: €201k. History available since 1 June 2021. The latest transaction was disclosed on 2 June 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
668 shares0Common StockSEC:0000816956-26-000069:0
1,000 shares@ US$55.7017.1% of flowCommon StockSEC:0001127602-25-016068:0
4,000 shares@ US$56.94270.4% of flowCommon StockSEC:0001127602-25-013471:0
1,000 shares@ US$39.6412.5% of flowCommon StockSEC:0001127602-24-023639:0
302 shares0Common StockSEC:0001127602-24-017849:0
335 shares0Common StockSEC:0001127602-23-017622:0
812 shares0Common StockSEC:0001127602-22-016538:0
1,521 shares0Common StockSEC:0001127602-21-018898:0
1,521 shares0Common StockSEC:0001127602-21-018898
332 sharesCommon StockSEC:0001127602-16-035487:0
Ideal exit: 30 Sept 2016 (T+270)
10 of 10 declarations
About Farkas Charles
Farkas Charles is a Board Member at CONMED Corp. He plays a key role in the governance of the company, contributing to strategy and oversight of operations. His expertise in the medical sector is an asset for innovation and growth.
